{
    "name": "maribavir",
    "comment": "Rx",
    "other_names": [
        "Livtencity"
    ],
    "classes": [
        "Antivirals",
        "CMV"
    ],
    "source": "https://reference.medscape.com/drug/livtencity-maribavir-4000225",
    "pregnancy": {
        "common": [
            "No adequate human data are available to establish drug-related risks to pregnancy outcomes"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "Embryofetal survival was decreased in rats at maribavir exposures less than those observed in humans at the recommended human dose (RHD)",
                    "Decreased number of viable fetuses and increase in early resorptions and post-implantation losses were observed at ≥100 mg/kg/day (at exposures approximately half the human exposure at the RHD)",
                    "Intermittent reduced body weight gain was observed in pregnant animals at ≥200 mg/kg/day"
                ]
            }
        ]
    },
    "lactation": null,
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [],
            "specific": [
                {
                    "type": "Virologic failure during treatment and relapse post-treatment",
                    "description": [
                        "Virologic failure due to resistance can occur during and after treatment",
                        "Virologic relapse during posttreatment period usually occurred within 4-8 weeks after treatment discontinuation",
                        "Monitor CMV DNA levels and check for maribavir resistance if nonresponsive to treatment or relapses occurs"
                    ]
                },
                {
                    "type": "Drug interaction overview ",
                    "description": [
                        "Substrate of CYP3A4; weak inhibitor of CYP3A4, P-gp, and BCRP",
                        "Strong CYP3A4 inducers (anticonvulsants)",
                        "Increase maribavir dose",
                        "Strong CYP3A4 inducers (eg, phenytoin, phenobarbital, carbamazepine) decrease maribavir plasma concentration and may result in reduced virologic response",
                        "Strong CYP3A4 inducers (other)",
                        "Not recommended",
                        "Strong CYP3A4 inducers (eg, rifabutin, rifampin, St. John’s wort) decrease maribavir plasma concentration and may result in reduced virologic response",
                        "Valganciclovir and ganciclovir",
                        "Not recommended",
                        "Maribavir may antagonize antiviral activity of ganciclovir and valganciclovir by inhibiting human CMV pUL97 kinase, which is required for activation/phosphorylation of ganciclovir and valganciclovir ",
                        "Immunosuppressants",
                        "Frequently monitor immunosuppressant drug levels during treatment, especially following initiation and after discontinuation and adjust immunosuppressant dose, as needed",
                        "Maribavir may increase concentrations of immunosuppressive drugs that are CYP3A4 and P-gp substrates (eg, tacrolimus, everolimus, sirolimus, cyclosporine) where minimal concentration changes may lead to serious adverse effects",
                        "Digoxin",
                        "Use with caution; monitor digoxin levels; digoxin dose may need to be reduced",
                        "Maribavir may increase digoxin levels by inhibiting P-gp",
                        "Rosuvastatin",
                        "Closely monitor for rosuvastatin-related events (eg, myopathy, rhabdomyolysis)",
                        "Maribavir may increase rosuvastatin levels"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Denotes incidence slightly less than investigator",
            "percent": "46"
        },
        {
            "name": "assigned treatment that was compared with maribavir",
            "percent": "1.5"
        },
        {
            "name": "Taste disturbance",
            "percent": "2.5"
        },
        {
            "name": "Creatinine",
            "percent": "33"
        },
        {
            "name": "to",
            "percent": "8"
        },
        {
            "name": "mg",
            "percent": "9.5"
        },
        {
            "name": "dL",
            "percent": "32"
        },
        {
            "name": "Hemoglobin",
            "percent": "21"
        },
        {
            "name": "to",
            "percent": "19"
        },
        {
            "name": "g",
            "percent": "50,000"
        },
        {
            "name": "dL",
            "percent": "100,000"
        },
        {
            "name": "Nausea",
            "percent": "18"
        },
        {
            "name": "Diarrhea",
            "percent": "6.5"
        },
        {
            "name": "Platelet cell count",
            "percent": "8"
        },
        {
            "name": "to",
            "percent": "15"
        },
        {
            "name": "cells",
            "percent": "14"
        },
        {
            "name": "µL",
            "percent": "12"
        },
        {
            "name": "Hemoglobin",
            "percent": "25,000"
        },
        {
            "name": "to",
            "percent": "50,000"
        },
        {
            "name": "g",
            "percent": "12"
        },
        {
            "name": "dL",
            "percent": "2.5"
        },
        {
            "name": "Vomiting",
            "percent": "7"
        },
        {
            "name": "Fatigue",
            "percent": "25,000"
        },
        {
            "name": "Platelet cell count",
            "percent": "5"
        },
        {
            "name": "to",
            "percent": "750"
        },
        {
            "name": "cells",
            "percent": "1,000"
        },
        {
            "name": "µL",
            "percent": "4"
        },
        {
            "name": "Creatinine",
            "percent": "500"
        },
        {
            "name": "mg",
            "percent": "750"
        },
        {
            "name": "dL",
            "percent": "3"
        },
        {
            "name": "Platelet cell count",
            "percent": "500"
        },
        {
            "name": "cells",
            "percent": "2"
        },
        {
            "name": "µL",
            "percent": "6.5"
        },
        {
            "name": "Neutrophils",
            "percent": "1"
        },
        {
            "name": "to",
            "percent": null
        },
        {
            "name": "cells",
            "percent": null
        },
        {
            "name": "µL",
            "percent": null
        },
        {
            "name": "Neutrophils",
            "percent": null
        },
        {
            "name": "to",
            "percent": null
        },
        {
            "name": "cells",
            "percent": null
        },
        {
            "name": "µL",
            "percent": null
        },
        {
            "name": "Neutrophils",
            "percent": null
        },
        {
            "name": "cells",
            "percent": null
        },
        {
            "name": "µL",
            "percent": null
        },
        {
            "name": "Hemoglobin",
            "percent": null
        },
        {
            "name": "g",
            "percent": null
        },
        {
            "name": "dL",
            "percent": null
        }
    ]
}